Svetlana Y. Erofeeva

Suggest Changes
Learn More
PURPOSE Fixed-combination drug products (FCDPs) combining dapagliflozin and metformin extended release (XR) may provide patients with type 2 diabetes mellitus with an alternative antihyperglycemic(More)
  • 1